Use and misuse of waterfall plots.
暂无分享,去创建一个
Tiffany Shao | Lisa Wang | Arnoud J Templeton | Raymond Jang | Francisco W Vera-Badillo | Mairead G McNamara | Myles Margolis | Tae Kyoung Kim | Mehrdad Sinaei | Hassan Shoushtari | Ian F Tannock | I. Tannock | M. McNamara | A. Templeton | M. Margolis | M. Sinaei | Hassan Shoushtari | Lisa Wang | T. Shao | Raymond Jang | F. Vera-Badillo | Tae Kyoung Kim
[1] Eric P Tamm,et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. , 2004, AJR. American journal of roentgenology.
[2] Jeffrey W. Clark,et al. Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Hanley,et al. The effect of measuring error on the results of therapeutic trials in advanced cancer , 1976, Cancer.
[4] L. Tanoue,et al. Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 Minutes , 2012 .
[5] Y. Rolland,et al. Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma , 2012, Cancer.
[6] Heber MacMahon,et al. Variability in mesothelioma tumor response classification. , 2006, AJR. American journal of roentgenology.
[7] I. Tannock,et al. Influence of measurement error on response rates. , 1985, Cancer treatment reports.
[8] G. Rosner,et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] I. Tannock,et al. Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Plimack,et al. Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] I. Tannock,et al. A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin , 2014, Investigational New Drugs.
[12] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[13] Heber MacMahon,et al. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. , 2004, Medical physics.
[14] L. Broemeling,et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.